CBD Life Sciences Inc.
CBDL · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $41 | $12 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $41 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -34.9% | 4.3% | 170.4% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9.1% | -18.3% | -174.9% | -250.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -644.3% | -13.8% | -503.1% | -8,255% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -695.4% | -47% | -536.6% | -8,654.2% |
| EPS Diluted | -0 | -0.001 | -0 | -0 |
| % Growth | 66.7% | -200% | 50% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |